A child with Polyglandular autoimmune syndrome
Type-I and immune thrombocytopenic purpura
Mohamad Pedram1, Korush Riahi2, Kaveh Jaseb3,Mohammad Hasan Alemzadeh Ansari4, Mohammad Javad Alemzadeh Ansari5ABSTRACT Polyglandular autoimmune syndrome type I (PGA I) is a rare disease. Its hallmarks are chronic mucocutaneous candidasis, hypoparathyroidism and adrenal insufficiency. Immune thrombocytopenic purpura (ITP) is one of the most common autoimmune disease in children. Association of PGA I with ITP was not found in some previous studies, but, we report a child with PGA I and ITP. KEY WORDS: ITP, Polyglandular autoimmune syndrome. Pak J Med Sci January - March 2011 Vol. 27 No. 1 223-225 How to cite this article: Pedram M, Riahi K, Jaseb K, Alemzadeh-Ansari MH, Alemzadeh-Ansari MJ. A child with Polyglandular autoimmune syndrome Type-I and immune thrombocytopenic purpura. Pak J Med Sci 2011;27(1):223-225 INTRODUCTION
Mohamad Pedram,Professor Pediatric Oncologist,
Polyglandular autoimmune syndrome type I (PGA
Research Center of Thalassemia & Hemoglobinopathy,
I) is a monogenic autosomal disease with a recessive
inheritance pattern. It is characterized by a widely
Jundishapour University of Medical Sciences,Ahvaz, Iran.
variable combination of autoimmune destruction of
tissues (predominantly endocrine glands), chronic
superficial candidiasis, and ectodermal dystrophy
complex including hypoplasia of the dental enamel,
Pediatric Hematology/Oncology Fellowship,
alopecia and nail dystrophy.1,2 Although, immune
thrombocytopenic purpura (ITP) had been reported
Mohammad Hasan Alemzadeh Ansari,Medical Student,
in PGA II and III,3 but in previous studies we did not
find any article reporting PGA I with ITP. Here, we
report a 5 years old boy who presented with a
Resident Cardiology, Tehran Heart Center Hospital,Tehran University of Medical Sciences, Tehran - Iran.
1-4: Jundishapour University of Medical Sciences,
CASE REPORT
A five years old boy was admitted to our hospital
with a four months history of multiple ecchymosis
on the lower limbs. This ecchymosis occurred after
Research Center of Thalassemia & Hemoglobinopathy,
mild injuries. On physical examination he had alope-
Shafa Hospital,Jundishapour University of Medical Sciences,
cia of head and neck and chronic mucocutaneous
candidiasis. (Figure-1,2) Other physical examination
Routin laboratory examination revealed platelets
7 4000 /mm3 (normal range 150 000-450 000 /mm3),
Partial thromboplastin time 41 sec (normal range
30-45 sec), Prothrombin time 13.7 sec (normal range
Pak J Med Sci 2011 Vol. 27 No. 1 www.pjms.com.pk 223
11-13 sec), and international normalized ratio 1.4. Other examination indicated serum calcium 5 mg/
dl (normal range 8.5-10.5 mg/dl), phosphate 12 mg/dl (normal range 3-6 mg/dl), serum albumin 5
develops or Addison’s disease is recognized in a
(normal range 4-6 g/dl). Serum cratinin, protein and
young child. The syndrome is rare but has an
electrolytes was normal. Parathormone hormone was
increased prevalence in certain populations (e.g.,
3.1 pg/dl (normal range 15-65 pg/dl). T3, TSH, T4,
inhabitants of Finland5 and Sardinia and Iranian
FTI and T3RU were in normal range but anti-TPO
Jews).6 Mutations in an autoimmune-suppressor
was 167.8 Iu/dl (normal range <34 Iu/dl). Serology
gene (AIRE, for autoimmune regulator), which en-
examinations was negative for anti-nuclear
codes a transcription factor, cause the syndrome.
Persons with any two of several specific conditions -
Electrocardiogram indicated high corrected QT
mucocutaneous candidiasis, hypoparathyroidism,
interval (0.52 sec). He was diagnosed to have PGA I
and Addison’s disease- almost always have AIRE
based on presence of hypoparathyroidism and
chronic muccocutaneous candidiasis. For approach
After diagnosis, patients with autoimmune
to thrombocytopenia, bone marrow aspiration was
polyendocrine syndrome type I require close moni-
done and its finding was compatible with ITP. After
toring. Monitoring can help prevent illness associ-
diagnosis of ITP, he was treated by Methylpredniso-
ated with delayed diagnosis of additional autoim-
lone 350 mg for five days. After five days the
mune diseases such as Addison’s disease and hypo-
platelets reached to normal range (375 000 /mm3).
parathyroidism, as well as oral cancer, which may
DISCUSSION
develop if candidiasis is not treated aggressively, and
infection due to asplenism, which is present in a sub-
PGA I has been described under other names, such
group of patients.9 Our patient was diagnosed PGA
as Whitaker’s syndrome, polyglandular autoimmune
I because this manifestations: hypoparathyroid,
disease type 1, or autoimmune polyendocrinopathy,
Chronic mucocutaneous candidiasis generally
PGA I is an autoimmune syndrome with charac-
presents earliest in life and is the most frequent of
teristic disease associations that often appear early
the three main diseases of PGA I. It can appear as
in life, typically in infants with persistent chronic
early as at the first month after birth up to 21 years
mucocutaneous candidiasis without the systemic in-
of age, with a peak of occurrence in early childhood.
fection generally associated with severe immunode-
Chronic mucocutaneous candidiasis is present in
polyendocrine syndrome type I is usually made later,
Chronic hypoparathyroidism is the first endocrine
when hypocalcemia due to hypoparathyroidism
disease to occur during the time course of PGA I,
224 Pak J Med Sci 2011 Vol. 27 No. 1 www.pjms.com.pk
usually after chronic mucocutaneous candidiasis and
2. Neufeld M, Maclaren NK, Blizzard RM. Two types of
before Addison’s disease, and can present between
autoimmune Addison’s disease associated with different
polyglandular autoimmune (PGA) syndromes. Medicine
three months to 44 years of age (mean, 7.5 yr).
Chronic hypoparathyroidism has been reported in
3. Noriko O, Junko T, Yuko Y, Toshiaki K, Masteru N, Tooru
Y, et al. Autoimmune Polyglandular Syndrome Type III
Associated with Slowly Progressive Type 1 Diabetes Melli-
tus, Chronic Thyroiditis, Pernicious Anemia and Idiopathic
disease in children. Acute ITP occurs in 90% of the
Thrombocytopenic Purpura: A Case Report. J Japan Diabetic
children. It is generally seen in children from the ages
of one to nine years, though the peak manifestation
4. Betterle C, Greggio NA, Volpato M. Clinical review 93:
Autoimmune Polyglandular Syndrome Type 1. JCE M
is between two to five years of age. The diagnosis of
ITP was demonstrated by bone marrow aspiration.
5. Perheentupa J. APS-I/APECED: The clinical disease
A treatment option is corticosteroidsý. Because our
and therapy. Endocrinol Metab Clin North Am
patient had multiple echemosis and thrombocytope-
6. Zlotogora J, Shapiro M.S. Polyglandular autoimmune syn-
nia, bone marrow aspiration was done. The result of
drome type I among Iranian Jews. J Med Genet
bone marrow aspiration confirmed the ITP. After
7. Eisenbarth GS, Gottlieb PA. Autoimmune Polyendocrine
treatment with Methylprednisolone 350 mg, the
Syndromes. N Engl J Med 2004;350:2068-2079.
platelets increased to normal range.
8. Barker JM, Eisenbarth GS. Autoimmune polyendocrine syn-
dromes. In: Eisenbarth GS, ed. Type 1 diabetes: Molecular,
REFERENCES
cellular, and clinical immunology. Denver: Barbara Davis
Center for Childhood Diabetes, 2003 (Web only). (Accessed
1. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical
April 20, 2004, at http://www.barbaradaviscenter.org.)
variation of autoimmune polyendocrinopathy-candidiasis-
9. Nugent DJ. Childhood immune thrombocytopenic purpura.
ectodermal dystrophy (APECED) in a series of 68 patients.
N Engl J Med 1990;322(26):1829-1836.
Pak J Med Sci 2011 Vol. 27 No. 1 www.pjms.com.pk 225
2014 Step Therapy Programs for Concordia Plan Services Medicare Members CONDITION TREATED STEP ONE DRUGS STEP TWO DRUGS Wil deny at pharmacy without trial of step-one drug Drug Class within the past 130 days. Prior authorization is required for use of step-two drug without use of step- one drug within past 130 days. BLOOD DISORDERSSP Erythroi
2014 Step Therapy Programs for Concordia Plan Services Medicare Members CONDITION TREATED STEP ONE DRUGS STEP TWO DRUGS Wil deny at pharmacy without trial of step-one drug Drug Class within the past 130 days. Prior authorization is required for use of step-two drug without use of step- one drug within past 130 days. BLOOD DISORDERSSP Erythroi